🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Ketan Patel

Ketan Patel

Managing Partner·F-Prime

Cambridge, MA, USA

Bio

Professional summary

Ketan Patel is a Managing Partner at F-Prime and has worked across healthcare as an investor, consultant, and physician. He focuses on therapeutics and medical device companies and has served on boards including ABK Biomedical, Aclaris Therapeutics, Avalyn Pharma, Avivomed, Bicara Therapeutics, Caplin Steriles, Comanche Biopharma, Enzene Biosciences, Ivenix, Rallybio, and Vicept Therapeutics. Before joining F-Prime in 2007, he advised biopharmaceutical and medical device companies at Leerink Swann & Company and trained in internal medicine at Weill Cornell Medical Center-New York Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.

Notable companies

Selected portfolio companies the partner has backed

ABK BiomedicalAclaris TherapeuticsAvalyn PharmaAvivomedBicara Therapeutics

Background

Career, education, and skills

Career history

  • F-Prime CapitalManaging Partner2007 – Present
  • Leerink Swann & CompanyCorporate Consulting Division
  • VA Boston Healthcare SystemPhysician
  • Weill Cornell Medical Center-New York Presbyterian HospitalResident Physician
  • Memorial Sloan Kettering Cancer CenterResident Physician

Education

  • Tufts University School of MedicineMD
  • Tufts UniversityMBA
  • Rutgers UniversityUndergraduate studies in Biology and Economics

Other partners at F-Prime

12 more profiles

Abdul Abdirahman

Abdul Abdirahman

Principal

F-Prime

Principal investing in early-stage B2B software, fintech, and vertical SaaS.

B2B softwareEarly-stage investingEmerging marketsFintechVertical SaaS
Alex Pasteur

Alex Pasteur

Partner

F-Prime

Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.

Life SciencesTherapeutics
AP

Anastasiya Sybirna, PhD

Senior Associate

F-Prime

Senior Associate on F-Prime's London healthcare investment team.

BiopharmaHealthcareLife sciencesPharmaceuticalsTherapeutics
Bala Varadhan

Bala Varadhan

Principal

F-Prime

Principal focused on early-stage crypto, blockchain and Web3 investments.

BlockchainCryptoDigital assetsEarly-stage investingWeb3
Benjamin Gorman

Benjamin Gorman

Principal

F-Prime

Principal investing in early-stage enterprise software and AI.

AIDataEarly-stage investingEnterprise softwareMachine learning
Betsy Mulé

Betsy Mulé

Principal

F-Prime

Principal investing in enterprise technology and robotics.

B2B softwareEarly-stage investingEnterprise technologyFrontier technologyRobotics
Brett Cook

Brett Cook

Partner

F-Prime

F-Prime Partner investing in healthcare technology and services companies.

care deliverydigital healthhealthcare datahealthcare serviceshealthcare technology
Brian Yordy

Brian Yordy

Principal

F-Prime

Principal investing in biopharmaceutical and medical technology companies.

BiopharmaceuticalsHealthcareLife sciencesMedical technologyTherapeutics
Carl Bradford Byers 🚑

Carl Bradford Byers 🚑

Partner

F-Prime

F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.

digital healthfintechhealthcare IThealthcare serviceshealthtech
Carl Byers

Carl Byers

Partner

F-Prime

Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.

HealthtechServices
Chance Mathisen

Chance Mathisen

Associate

F-Prime

Associate focused on early-stage enterprise software investments.

AIEarly-stage investingEnterprise softwareGo-to-market strategySoftware platforms
Chong Xu

Chong Xu

Partner

F-Prime

F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.

BiopharmaceuticalsChina healthcareCompany formationHealthcare investingMedical technology